Barcelona, Spain

Anna Nardi Ricart

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Som Innovation Biotech, S.l., Intas Pharmaceuticals Limited. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Nardi Ricart. Retrieved from https://idiyas.com/inventor/anna-nardi-ricart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Nardi Ricart

Introduction

Anna Nardi Ricart is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release compositions. With a total of 3 patents, her work focuses on innovative solutions for medical treatments.

Latest Patents

Anna's latest patents include a sustained release tablet comprising micronized tolcapone. This invention is designed for the prevention and treatment of transthyretin-associated amyloidosis. The patent details a method for administering an effective amount of the tablet to subjects in need, as well as the pharmaceutical composition and the process for manufacturing the tablet. This innovative approach aims to improve patient outcomes in managing this complex condition.

Career Highlights

Throughout her career, Anna has worked with notable companies such as Som Innovation Biotech and Intas Pharmaceuticals Limited. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Anna has collaborated with talented individuals in her field, including Núria Reig Bolaño and Raúl Insa Boronat. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Anna Nardi Ricart's contributions to the field of pharmaceuticals through her patents and collaborations highlight her dedication to advancing medical treatments. Her work continues to impact the lives of those affected by transthyretin-associated amyloidosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…